Establishment Labs Holdings (ESTA) Net Cash Flow (2017 - 2026)
Establishment Labs Holdings' (ESTA) quarterly Net Cash Flow came in at -$7.1 million in Q1 2026, up 67.96% year-on-year from -$4.2 million in Q1 2025, and down 268.61% quarter-over-quarter from $4.2 million in Q4 2025.
Establishment Labs Holdings (ESTA) Net Cash Flow (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$7.1 million for Q1 2026.
- On a quarterly basis, Net Cash Flow rose 67.96% year-over-year to -$7.1 million in Q1 2026; TTM through Mar 2026 was -$2.4 million, a 37.41% increase from a year earlier, with the FY2025 full-year figure at -$17.5 million, down 133.77% from the prior year.
- Net Cash Flow fell to -$7.1 million in Q1 2026 per ESTA's latest filing, from $4.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $51.9 million in Q4 2024 and bottomed at -$37.6 million in Q3 2023.
- The 5-year median for Net Cash Flow is -$8.9 million (2022), against an average of $800882.4.
- Across the five-year window, Net Cash Flow jumped 3660.3% in 2022 and slumped 2483.3% in 2023, its largest moves.
- Year by year, Net Cash Flow stood at $533000.0 in 2022, then slumped by 2483.3% to -$12.7 million in 2023, then soared by 508.75% to $51.9 million in 2024, then sank by 91.85% to $4.2 million in 2025, then slumped by 268.61% to -$7.1 million in 2026.
- Per Business Quant, the three latest ESTA Net Cash Flow figures stand at -$7.1 million (Q1 2026), $4.2 million (Q4 2025), and $16.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Establishment Labs Holdings | 2.73 Bn | 2.66 Bn | 42.34 Mn | -7.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.13 Mn |
| Mar 31, 2026 | -7.13 Mn |
| Dec 31, 2025 | 4.23 Mn |
| Dec 31, 2025 | 4.23 Mn |
| Sep 30, 2025 | 16.24 Mn |
| Sep 30, 2025 | 16.24 Mn |
| Jun 30, 2025 | -15.70 Mn |
| Jun 30, 2025 | -15.70 Mn |
| Mar 31, 2025 | -22.26 Mn |
| Mar 31, 2025 | -22.26 Mn |
| Dec 31, 2024 | 51.92 Mn |
| Dec 31, 2024 | 51.92 Mn |
| Sep 30, 2024 | -15.25 Mn |
| Sep 30, 2024 | -15.25 Mn |
| Jun 30, 2024 | -18.17 Mn |
| Jun 30, 2024 | -18.17 Mn |
| Mar 31, 2024 | 33.27 Mn |
| Mar 31, 2024 | 33.27 Mn |
| Dec 31, 2023 | -12.70 Mn |
| Dec 31, 2023 | -12.70 Mn |